INDRAMEDCO vs JLHL: Stock Comparison

Indraprastha Medical Corporation Limited vs Jupiter Life Line Hospitals Limited

Live data: 16 July 2026, 12:36 PM IST • Source: NSE and company filings

Jupiter Life Line Hospitals Limited is the larger company by market capitalisation. Indraprastha Medical Corporation Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Jupiter Life Line Hospitals Limited shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Indraprastha Medical Corporation Limited and Jupiter Life Line Hospitals Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDRAMEDCO is more favourable on 6 of 13 scored metrics and JLHL on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
JLHL is the larger company
₹10,173 Cr vs ₹3,437 Cr
P/E Ratio
INDRAMEDCO has a lower P/E
19.06x vs 48.96x
P/B Ratio
INDRAMEDCO has a lower P/B
4.73x vs 6.31x
EPS
JLHL has higher earnings per share
₹29.59 vs ₹20.04
Dividend Yield
INDRAMEDCO has a higher dividend yield
1.19% vs 0.14%
Revenue Growth (TTM YoY)
JLHL has faster revenue growth
17.1% vs 9.3%
EPS Growth (TTM YoY)
JLHL has faster EPS growth
12% vs 1.8%
Qtr Sales Growth
JLHL has stronger quarterly sales growth
15.2% vs 9.31%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDRAMEDCOJLHL
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricINDRAMEDCOJLHL
Live Price₹375.7₹1,561
Day Change-0.32%4.08%
Volume54,42488,710
52-Week High₹640.85₹1,625
52-Week Low₹342₹1,178
Distance from 52W High-41.37%-3.94%

Valuation

MetricINDRAMEDCOJLHL
Market Cap₹3,437 Cr₹10,173 Cr
P/E Ratio19.06x48.96x
P/B Ratio4.73x6.31x
EPS₹20.04₹29.59
Book Value₹80.78₹235.5
Dividend Yield1.19%0.14%

Growth

MetricINDRAMEDCOJLHL
Revenue Growth (TTM YoY)9.3%17.1%
EPS Growth (TTM YoY)1.8%12%
Qtr Sales Growth9.31%15.2%
Qtr Profit Growth1.68%8.66%

Profitability & Leverage

MetricINDRAMEDCOJLHL
ROE27.5%13.1%
ROCE35.8%14.8%
Net Margin12.21%13.01%
Operating Margin18%22.9%
Debt to Equity0x0x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricINDRAMEDCOJLHL
Promoter Holding49.39%40.91%
FII Holding2.44% 0.29 pp8.48%
DII Holding0.88% 0.05 pp17.01% 0.42 pp
Public Holding45.69% 0.25 pp33.6% 0.43 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Indraprastha Medical Corporation Limited and Jupiter Life Line Hospitals Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.